Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
暂无分享,去创建一个
Patricia S. Goldman-Rakic | Larry J. Siever | Stacy A. Castner | L. Siever | P. Goldman-Rakic | Graham V. Williams | T. Svensson | S. Castner | Torgny H. Svensson
[1] Richard Coppola,et al. Effects of Dextroamphetamine on Cognitive Performance and Cortical Activation , 2000, NeuroImage.
[2] Sharon K. McDowell,et al. A Role for Dopamine in Executive Function Deficits , 1996 .
[3] D. Amaral,et al. Evidence for task-dependent memory dysfunction in the aged monkey , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[4] J. Schneider,et al. Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[5] Emil Kraepelin,et al. Dementia praecox and paraphrenia , 2002 .
[6] Y. Khan,et al. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[7] P. Goldman-Rakic,et al. Long-Lasting Psychotomimetic Consequences of Repeated Low-Dose Amphetamine Exposure in Rhesus Monkeys , 1999, Neuropsychopharmacology.
[8] Xuechu Zhen,et al. SKF83959 selectively regulates phosphatidylinositol‐linked D1 dopamine receptors in rat brain , 2003, Journal of neurochemistry.
[9] P. Goldman-Rakic,et al. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. , 1993, Cerebral cortex.
[10] P. Goldman-Rakic,et al. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.
[11] P S Goldman-Rakic,et al. Prominence of the dopamine D2 short isoform in dopaminergic pathways. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Goldman-Rakic,et al. D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.
[13] P. Goldman-Rakic,et al. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys , 1994, Psychopharmacology.
[14] K. Suzuki,et al. Age-related changes in human D1 dopamine receptors measured by positron emission tomography , 2005, Psychopharmacology.
[15] T E Smith,et al. Symptoms and neurocognition as rate limiters in skills training for psychotic patients. , 1999, The American journal of psychiatry.
[16] Hank P Jedema,et al. Clozapine Preferentially Increases Dopamine Release in the Rhesus Monkey Prefrontal Cortex Compared with the Caudate Nucleus , 1999, Neuropsychopharmacology.
[17] D. Mash,et al. Dopamine transporter‐immunoreactive neurons decrease with age in the human substantia nigra , 1999, The Journal of comparative neurology.
[18] J. S. Schneider,et al. Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys , 1994, Pharmacology Biochemistry and Behavior.
[19] CR Yang,et al. Dopamine D1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[20] Shoji Tanaka,et al. Dopamine controls fundamental cognitive operations of multi-target spatial working memory , 2002, Neural Networks.
[21] Herbert Y Meltzer,et al. The role of cognition in vocational functioning in schizophrenia , 2000, Schizophrenia Research.
[22] R. Saunders,et al. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.
[23] T. Robbins,et al. Spatial and non-spatial working memory at different stages of Parkinson's disease , 1997, Neuropsychologia.
[24] S. Sevy,et al. The cost of cognitive impairment in schizophrenia , 1995, Schizophrenia Research.
[25] P. Seeman,et al. Dopamine receptors and the dopamine hypothesis of schizophrenia , 1987, Synapse.
[26] R. Roth,et al. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. , 1990, Brain : a journal of neurology.
[27] D. Weinberger,et al. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.
[28] K. Perry,et al. Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder , 2002, Neuropsychopharmacology.
[29] D. Durstewitz,et al. Bidirectional Dopamine Modulation of GABAergic Inhibition in Prefrontal Cortical Pyramidal Neurons , 2001, The Journal of Neuroscience.
[30] R. V. Van Heertum,et al. Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.
[31] P. Goldman-Rakic,et al. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. , 1994, Journal of neurophysiology.
[32] J. Trojanowski,et al. Neuron‐specific age‐related decreases in dopamine receptor subtype mRNAs , 2003, The Journal of comparative neurology.
[33] M. Goodman,et al. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. , 1999, The Journal of nervous and mental disease.
[34] T. Robbins,et al. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. , 2002, Brain : a journal of neurology.
[35] P. Goldman-Rakic,et al. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] Michael F. Green,et al. What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.
[37] J. Kulisevsky,et al. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two‐year follow‐up study of previously untreated patients , 2000, Movement disorders : official journal of the Movement Disorder Society.
[38] D. Brooks,et al. Evidence for striatal dopamine release during a video game , 1998, Nature.
[39] J. Seamans,et al. Developing a Neuronal Model for the Pathophysiology of Schizophrenia Based on the Nature of Electrophysiological Actions of Dopamine in the Prefrontal Cortex , 1999, Neuropsychopharmacology.
[40] A. C. Roberts,et al. Perseveration and Strategy in a Novel Spatial Self-Ordered Sequencing Task for Nonhuman Primates: Effects of Excitotoxic Lesions and Dopamine Depletions of the Prefrontal Cortex , 1998, Journal of Cognitive Neuroscience.
[41] C. Cepeda,et al. Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex , 1992, Synapse.
[42] 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner. , 2002, Brain research.
[43] G. Vauquelin,et al. The effect of aging on the D1 dopamine receptors in human frontal cortex , 1990, Brain Research.
[44] F. Tarazi,et al. Brain Dopamine Receptors: A Primer on Their Current Status, Basic and Clinical , 1996, Harvard review of psychiatry.
[45] D. R. Snyder,et al. Effects of orbital frontal lesions on aversive and aggressive behaviors in rhesus monkeys. , 1970, Journal of comparative and physiological psychology.
[46] P. Goldman-Rakic,et al. Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates , 2003, Biological Psychiatry.
[47] H R Johnson,et al. Aging in the rhesus monkey: debilitating effects on short-term memory. , 1978, Journal of gerontology.
[48] S. Pollmann,et al. D1- Versus D2-Receptor Modulation of Visuospatial Working Memory in Humans , 1998, The Journal of Neuroscience.
[49] R. Roth,et al. Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys , 1999, Psychopharmacology.
[50] Daniel Durstewitz,et al. The computational role of dopamine D1 receptors in working memory , 2002, Neural Networks.
[51] Philip D. Harvey,et al. A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia , 1995, Schizophrenia Research.
[52] A. Sidhu,et al. Coupling of Human D-1 Dopamine Receptors to Different Guanine Nucleotide Binding Proteins. EVIDENCE THAT D-1 DOPAMINE RECEPTORS CAN COUPLE TO BOTH Gs AND Go(*) , 1995, The Journal of Biological Chemistry.
[53] A. Sampson,et al. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. , 1999, The American journal of psychiatry.
[54] K. Davis,et al. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls. , 1988, Archives of general psychiatry.
[55] D. Weinberger,et al. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. , 1988, Archives of general psychiatry.
[56] M. Le Moal,et al. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. , 1996, The Journal of pharmacology and experimental therapeutics.
[57] M. Mishkin,et al. Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction , 1991, Neurobiology of Aging.
[58] S. Rauch,et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance , 2000, Biological Psychiatry.
[59] M. Naoi,et al. Cell death of dopamine neurons in aging and Parkinson’s disease , 1999, Mechanisms of Ageing and Development.
[60] R E Passingham. Memory of monkeys (Macaca mulatta) with lesions in prefrontal cortex. , 1985, Behavioral neuroscience.
[61] A. Arnsten,et al. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. , 1997, The Journal of pharmacology and experimental therapeutics.
[62] A. Sidhu,et al. Multiple Coupling of Human D5 Dopamine Receptors to Guanine Nucleotide Binding Proteins GS and Gz , 1998, Journal of neurochemistry.
[63] T. Goldberg,et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease , 2002, Annals of neurology.
[64] P. Liddle. Cognitive impairment in schizophrenia:its impact on social functioning , 2000, Acta psychiatrica Scandinavica. Supplementum.
[65] C. Caltagirone,et al. Dopaminergic Modulation of Visual-Spatial Working Memory in Parkinson’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.
[66] A. Carlsson,et al. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.
[67] D. Weinberger,et al. 59 NEUROCHEMICAL AND NEUROPHARMACOLOGICAL IMAGING IN SCHIZOPHRENIA , 2002 .
[68] Schizophrenia from a neurocognitive perspective: probing the impenetrable darkness , 2000 .
[69] F. Mora,et al. Endogenous dopamine potentiates the effects of glutamate on extracellular GABA in the prefrontal cortex of the freely moving rat , 2000, Brain Research Bulletin.
[70] J. Pierri,et al. Decreased density of tyrosine hydroxylase–immunoreactive axons in the entorhinal cortex of schizophrenic subjects , 2000, Biological Psychiatry.
[71] J. Holden,et al. Age‐dependent decline of dopamine D1 receptors in human brain: A PET study , 1998, Synapse.
[72] P. Goldman-Rakic,et al. Enhancement of Working Memory in Aged Monkeys by a Sensitizing Regimen of Dopamine D1 Receptor Stimulation , 2004, The Journal of Neuroscience.
[73] J. Cohen,et al. Functional hypofrontality and working memory dysfunction in schizophrenia. , 1998, The American journal of psychiatry.
[74] L. Wilkinson. The nature of interactions involving prefrontal and striatal dopamine systems , 1997, Journal of psychopharmacology.
[75] C. Harris,et al. Adult attention-deficit/hyperactivity disorder: Neuropsychological correlates and clinical presentation , 2001, Brain and Cognition.
[76] M. Williams,et al. Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data. , 2006, CNS drug reviews.
[77] H. Meltzer,et al. 5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner , 2002, Brain Research.
[78] D. Price,et al. Age-related changes in multiple neurotransmitter systems in the monkey brain , 1989, Neurobiology of Aging.
[79] T. Aigner,et al. Long-term cognitive impairment in MPTP-treated Rhesus monkeys , 1995, Neuroreport.
[80] P. Seeman,et al. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains , 1978, Nature.
[81] H. Herken,et al. Catechol‐O ‐methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis , 2001, Psychiatric genetics.
[82] F. Gonon,et al. Excitatory effects of dopamine released by impulse flow in the rat nucleus accumbens in vivo , 1996, Neuroscience.
[83] B. Kolachana,et al. Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human Brain , 2003, The Journal of Neuroscience.
[84] R. Kessler,et al. Cognition, schizophrenia, and the atypical antipsychotic drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[85] R. Godbout,et al. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization. , 1991, The Journal of pharmacology and experimental therapeutics.
[86] J. Schneider,et al. Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys , 1993, Brain Research.
[87] Tim Shallice,et al. Executive Function Profile of Children With Attention Deficit Hyperactivity Disorder , 2002, Developmental neuropsychology.
[88] R. Godbout,et al. Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: Evidence for the involvement of both dopaminergic and GABAergic components , 1992, Neuroscience.
[89] T. Robbins,et al. The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function. , 2000, Behavioral neuroscience.
[90] A. Malhotra,et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.
[91] P. Goldman-Rakic,et al. Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[92] J. Krystal,et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[93] G. Pearlson,et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.
[94] P. Vezina,et al. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[95] P. Goldman-Rakic,et al. D 1 Receptor in Interneurons of Macaque Prefrontal Cortex : Distribution and Subcellular Localization , 1998 .
[96] J. Lieberman,et al. Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia , 2002, Biological Psychiatry.
[97] I. Creese,et al. Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia. , 1986, Clinical neuropharmacology.
[98] A. Meyer-Lindenberg,et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia , 2002, Nature Neuroscience.
[99] P. Goldman-Rakic,et al. Distribution of dopaminergic receptors in the primate cerebral cortex: Quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390 , 1991, Neuroscience.
[100] Larry J. Siever,et al. Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder , 1995, Psychiatry Research.
[101] T. Svensson,et al. Noradrenaline Reuptake Inhibition Enhances the Antipsychotic-like Effect of Raclopride and Potentiates D2-blockage–induced Dopamine Release in the Medial Prefrontal Cortex of the Rat , 2002, Neuropsychopharmacology.
[102] W. Schultz. Getting Formal with Dopamine and Reward , 2002, Neuron.
[103] Daniel R. Weinberger,et al. Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.
[104] T. Svensson. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs , 2000, Brain Research Reviews.
[105] H. C. Cromwell,et al. Electrophysiological and Morphological Analyses of Cortical Neurons Obtained from Children with Catastrophic Epilepsy: Dopamine Receptor Modulation of Glutamatergic Responses , 1999, Developmental Neuroscience.
[106] H. Meltzer,et al. 5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release , 2001, Journal of neurochemistry.
[107] P. Kalivas,et al. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity , 1991, Brain Research Reviews.
[108] A. Walters,et al. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. , 2000, Pediatric neurology.
[109] R. Roth,et al. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. , 1997, Science.
[110] P. O’Donnell,et al. D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons. , 2001, Cerebral cortex.
[111] Philip D. Harvey,et al. Effects of Amphetamine on Visuospatial Working Memory Performance in Schizophrenia Spectrum Personality Disorder , 2000, Neuropsychopharmacology.
[112] J. Millar,et al. Concentration-dependent actions of stimulated dopamine release on neuronal activity in rat striatum , 1990, Neuroscience.
[113] Marc Laruelle,et al. Dopamine Depletion and In Vivo Binding of PET D1 Receptor Radioligands: Implications for Imaging Studies in Schizophrenia , 2003, Neuropsychopharmacology.
[114] Päivi Marjamäki,et al. Age-dependent decline in human brain dopamine D1 and D2 receptors , 1990, Brain Research.
[115] Sohee Park,et al. Schizophrenics show spatial working memory deficits. , 1992, Archives of general psychiatry.
[116] D. Sibley,et al. Molecular characteristics of mammalian dopamine receptors. , 1997, Pharmacology & toxicology.
[117] P. Goldman-Rakic,et al. Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys , 1981, Neuroscience.
[118] H Y Wang,et al. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. , 1995, Molecular pharmacology.
[119] N. Keks. Impact of newer antipsychotics on outcomes in schizophrenia. , 1997, Clinical therapeutics.
[120] Y. Miyashita,et al. Functional MRI of Macaque Monkeys Performing a Cognitive Set-Shifting Task , 2002, Science.
[121] D. Weinberger,et al. Cognitive function in schizophrenia , 1997, International clinical psychopharmacology.
[122] T. Kimura,et al. Differential Expression of an Acidic Domain in the Amino-terminal Propeptide of Mouse Pro-2(XI) Collagen by Complex Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.
[123] P. Goldman-Rakic,et al. The cerebral cortex: a case for a common site of action of antipsychotics. , 1998, Trends in pharmacological sciences.
[124] H. Meltzer. Outcome in schizophrenia: beyond symptom reduction. , 1999, The Journal of clinical psychiatry.
[125] U. Ungerstedt,et al. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. , 1970, European journal of pharmacology.
[126] V. Luine,et al. Spatial memory deficits in aged rats: contributions of monoaminergic systems , 1990, Brain Research.
[127] J. Krystal,et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. , 1998, The American journal of psychiatry.
[128] P. Goldman-Rakic,et al. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. , 2000, Science.
[129] Daniel R. Weinberger,et al. Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine , 1998, Nature.
[130] J. Fuster,et al. Delayed-matching and delayed-response deficit from cooling dorsolateral prefrontal cortex in monkeys. , 1976, Journal of comparative and physiological psychology.
[131] M. Iyo,et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.
[132] J. Rotrosen,et al. Amphetamine response and relapse risk after depot neuroleptic discontinuation , 2004, Psychopharmacology.
[133] P. Goldman-Rakic,et al. Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. , 1993, Cerebral cortex.
[134] Trevor W. Robbins,et al. Enhanced and Impaired Attentional Performance After Infusion of D1 Dopaminergic Receptor Agents into Rat Prefrontal Cortex , 2000, The Journal of Neuroscience.
[135] S. Siris,et al. Implications of normal brain development for the pathogenesis of schizophrenia. , 1988, Archives of general psychiatry.
[136] C. Bruce,et al. Primate frontal eye fields. I. Single neurons discharging before saccades. , 1985, Journal of neurophysiology.
[137] P. Goldman-Rakic,et al. A common action of clozapine , haloperidol , and remoxipride on D 1-and D 2-dopaminergic receptors in the primate cerebral cortex ( neuroleptic drugs / schizophrenia / asociatlon cortex / receptor autoradiography / receptor regulation ) , 2004 .
[138] Kisou Kubota,et al. Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex , 1988, Neuroscience Research.
[139] Charles R. Yang,et al. Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex. , 2002, Journal of neurophysiology.
[140] M. Laruelle,et al. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies , 1999, Journal of psychopharmacology.
[141] P. Goldman-Rakic,et al. The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia , 1999, Biological Psychiatry.
[142] P. Goldman-Rakic. Working memory dysfunction in schizophrenia. , 1994, The Journal of neuropsychiatry and clinical neurosciences.
[143] P. Goldman-Rakic,et al. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[144] D. Hell,et al. Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study , 1999, Biological Psychiatry.
[145] Philip D. Harvey,et al. Visuospatial working memory in schizotypal personality disorder patients , 2000, Schizophrenia Research.
[146] P. Goldman-Rakic,et al. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. , 1997, The Journal of pharmacology and experimental therapeutics.
[147] J. Schneider,et al. Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys , 1994, Brain Research.
[148] Hideo Tsukada,et al. Age‐related changes in the striatal dopaminergic system in the living brain: A multiparametric PET study in conscious monkeys , 2002, Synapse.
[149] Juan Fernández-Ruiz,et al. Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys , 1999, Psychopharmacology.
[150] P. Goldman-Rakic,et al. Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging. , 1998, Archives of general psychiatry.
[151] M Masellis,et al. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine , 2003, Molecular Psychiatry.
[152] L L Iversen,et al. Increased brain dopamine and dopamine receptors in schizophrenia. , 1982, Archives of general psychiatry.
[153] Philip Seeman,et al. Atypical Antipsychotics: Mechanism of Action , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[154] J. Schneider,et al. The Subtype Selective Nicotinic Acetylcholine Receptor Agonist SIB1553 SIB1553 SIB1553 A Improves Both Attention and Memory Components of A Spatial Working Memory Task in Chronic Low Dose MPTPTreated MPTPTreated MPTPTreated Monkeys , 2003 .
[155] N Butters,et al. Behavioral deficits in monkeys after selective lesions within the middle third of sulcus principalis. , 1971, Journal of comparative and physiological psychology.
[156] R. Roth,et al. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits , 1999, Neuroscience.
[157] Nancy C. Andreasen,et al. Linking Mind and Brain in the Study of Mental Illnesses: A Project for a Scientific Psychopathology , 1997, Science.
[158] M. Bell,et al. Performance on the Wisconsin Card Sorting Test as a predictor of rehospitalization in schizophrenia. , 1996, The Journal of nervous and mental disease.
[159] Douglas W. Jones,et al. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[160] T. Goldberg,et al. Cognitive impairment in schizophrenia is the core of the disorder. , 2000, Critical reviews in neurobiology.
[161] G. Sedvall,et al. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. , 2002, The American journal of psychiatry.
[162] R. Coppola,et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.
[163] P. Goldman-Rakic,et al. Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex. , 1989, Journal of neurophysiology.
[164] D. Weinberger,et al. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. , 1986, Archives of general psychiatry.
[165] P. Goldman-Rakic,et al. Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.
[166] J. Fuster. Prefrontal Cortex , 2018 .
[167] F. J. White,et al. Synaptic regulation of mesocorticolimbic dopamine neurons. , 1996, Annual review of neuroscience.
[168] Paul Greengard,et al. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. , 2002, Archives of general psychiatry.
[169] L. Siever,et al. D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder , 1996, Schizophrenia Research.
[170] T. Sawaguchi,et al. Effects of dopamine antagonists on neuronal activity related to a delayed response task in monkey prefrontal cortex. , 1990, Journal of neurophysiology.
[171] P. Goldman-Rakic,et al. D1 Receptor in Interneurons of Macaque Prefrontal Cortex: Distribution and Subcellular Localization , 1998, The Journal of Neuroscience.
[172] J. Kebabian,et al. Pharmacological and Biochemical Evidence for the Existence of Two Categories of Dopamine Receptor , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[173] J. Callicott,et al. The Relationship between Dorsolateral Prefrontal Neuronal N-Acetylaspartate and Evoked Release of Striatal Dopamine in Schizophrenia , 2000, Neuropsychopharmacology.
[174] P. Goldman-Rakic,et al. Dorsolateral prefrontal lesions and oculomotor delayed-response performance: evidence for mnemonic "scotomas" , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[175] P S Goldman-Rakic,et al. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[176] T. Sejnowski,et al. Neurocomputational models of working memory , 2000, Nature Neuroscience.
[177] R. Wurtz,et al. Visual and oculomotor functions of monkey substantia nigra pars reticulata. III. Memory-contingent visual and saccade responses. , 1983, Journal of neurophysiology.
[178] Michael J. Bannon,et al. Age‐related and regional differences in dopamine transporter mRNA expression in human midbrain , 1997, Neurology.
[179] T. Robinson,et al. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.
[180] S. Sesack,et al. Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. , 1998, Cerebral cortex.
[181] F. Gonon. Prolonged and Extrasynaptic Excitatory Action of Dopamine Mediated by D1 Receptors in the Rat Striatum In Vivo , 1997, The Journal of Neuroscience.
[182] H. E. Rosvold,et al. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.
[183] P. Greengard,et al. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons , 1995, Neuron.
[184] A. M. Owen,et al. Visuospatial memory deficits at different stages of Parkinson's disease , 1993, Neuropsychologia.
[185] M. Laruelle,et al. Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.
[186] H. Meltzer,et al. Neuropsychologic deficits in schizophrenia : Relation to social function and effect of antipsychotic drug treatment , 1996 .
[187] R. Buchanan,et al. Association between Val108/158 met polymorphism of the COMT gene and schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[188] P S Goldman-Rakic,et al. Association of Storage and Processing Functions in the Dorsolateral Prefrontal Cortex of the Nonhuman Primate , 1999, The Journal of Neuroscience.
[189] J. Lieberman,et al. Methylphenidate challenge as a predictor of relapse in schizophrenia. , 1984, The American journal of psychiatry.
[190] T. Inada,et al. Relationship between catechol‐O‐methyltransferase polymorphism and treatment‐resistant schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[191] P. Goldman-Rakic,et al. Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia. , 2003, Archives of general psychiatry.
[192] V. Sethy,et al. D1 dopamine receptor activity of anti-parkinsonian drugs. , 1997, Life sciences.
[193] J. Schneider,et al. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys. , 1999, The Journal of pharmacology and experimental therapeutics.
[194] P. Goldman-Rakic,et al. Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC. , 1999, Journal of neurophysiology.
[195] C. Gonzalez-Islas,et al. Dopamine Enhances EPSCs in Layer II–III Pyramidal Neurons in Rat Prefrontal Cortex , 2003, The Journal of Neuroscience.
[196] C. Marsden,et al. l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction , 2005, Psychopharmacology.
[197] R. Straub,et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[198] A. Sampson,et al. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. , 2001, Archives of general psychiatry.
[199] P. Goldman-Rakic,et al. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. , 2000, Science.
[200] J. Hauser,et al. Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene , 2002, Psychiatry Research.
[201] R. Desimone. Is dopamine a missing link? , 1995, Nature.
[202] K. Davis,et al. Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.
[203] Thomas E. Nichols,et al. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. , 1997, The American journal of psychiatry.